Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Zhang S, Wang R, Wang X, Guo X, et al. HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer. J Biol Chem 2022 Jan 27:101644. doi: 10.1016/j.jbc.2022.101644.
PMID: 35093383


Privacy Policy